Pirmohamed M - Search Results

1

Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood Asthma.

Hernandez-Pacheco N, Gorenjak M, Li J, Repnik K, Vijverberg SJ, Berce V, Jorgensen A, Karimi L, Schieck M, Samedy-Bates LA, Tavendale R, Villar J, Mukhopadhyay S, Pirmohamed M, Verhamme KMC, Kabesch M, Hawcutt DB, Turner S, Palmer CN, Tantisira KG, Burchard EG, Maitland-van der Zee AH, Flores C, Potočnik U, Pino-Yanes M. Hernandez-Pacheco N, et al. Among authors: pirmohamed m. J Pers Med. 2021 Jul 28;11(8):733. doi: 10.3390/jpm11080733. J Pers Med. 2021. PMID: 34442380 Free PMC article.

2

Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study.

Leschziner G, Jorgensen AL, Andrew T, Pirmohamed M, Williamson PR, Marson AG, Coffey AJ, Middleditch C, Rogers J, Bentley DR, Chadwick DW, Balding DJ, Johnson MR. Leschziner G, et al. Among authors: pirmohamed m. Lancet Neurol. 2006 Aug;5(8):668-76. doi: 10.1016/S1474-4422(06)70500-2. Lancet Neurol. 2006. PMID: 16857572

3

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.

Alfirevic A, Jorgensen AL, Williamson PR, Chadwick DW, Park BK, Pirmohamed M. Alfirevic A, et al. Among authors: pirmohamed m. Pharmacogenomics. 2006 Sep;7(6):813-8. doi: 10.2217/14622416.7.6.813. Pharmacogenomics. 2006. PMID: 16981842

4

Effects of CYP4F2 genetic polymorphisms and haplotypes on clinical outcomes in patients initiated on warfarin therapy.

Zhang JE, Jorgensen AL, Alfirevic A, Williamson PR, Toh CH, Park BK, Pirmohamed M. Zhang JE, et al. Among authors: pirmohamed m. Pharmacogenet Genomics. 2009 Oct;19(10):781-9. doi: 10.1097/FPC.0b013e3283311347. Pharmacogenet Genomics. 2009. PMID: 19741565

5

Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.

Mirza NS, Alfirevic A, Jorgensen A, Marson AG, Pirmohamed M. Mirza NS, et al. Among authors: pirmohamed m. Pharmacogenet Genomics. 2011 May;21(5):297-302. doi: 10.1097/FPC.0b013e3283441b95. Pharmacogenet Genomics. 2011. PMID: 21278619

6

Risk modeling strategies for pharmacogenetic studies.

Jorgensen AL, Pirmohamed M. Jorgensen AL, et al. Among authors: pirmohamed m. Pharmacogenomics. 2011 Mar;12(3):397-410. doi: 10.2217/pgs.10.198. Pharmacogenomics. 2011. PMID: 21449678 Review.

7

Reported paediatric adverse drug reactions in the UK 2000-2009.

Hawcutt DB, Mainie P, Riordan A, Smyth RL, Pirmohamed M. Hawcutt DB, et al. Among authors: pirmohamed m. Br J Clin Pharmacol. 2012 Mar;73(3):437-46. doi: 10.1111/j.1365-2125.2011.04113.x. Br J Clin Pharmacol. 2012. PMID: 21988288 Free PMC article. Review.

8

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis.

Jorgensen AL, FitzGerald RJ, Oyee J, Pirmohamed M, Williamson PR. Jorgensen AL, et al. Among authors: pirmohamed m. PLoS One. 2012;7(8):e44064. doi: 10.1371/journal.pone.0044064. Epub 2012 Aug 29. PLoS One. 2012. PMID: 22952875 Free PMC article. Review.

9

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.

Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A. Yip VL, et al. Among authors: pirmohamed m. Clin Pharmacol Ther. 2012 Dec;92(6):757-65. doi: 10.1038/clpt.2012.189. Epub 2012 Nov 7. Clin Pharmacol Ther. 2012. PMID: 23132554 Review.

10

Paediatric pharmacogenomics: an overview.

Hawcutt DB, Thompson B, Smyth RL, Pirmohamed M. Hawcutt DB, et al. Among authors: pirmohamed m. Arch Dis Child. 2013 Mar;98(3):232-7. doi: 10.1136/archdischild-2012-302852. Epub 2012 Nov 29. Arch Dis Child. 2013. PMID: 23196740 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

661 results

Search Page